期刊文献+

应对耐药菌的新方法—噬菌体制剂 被引量:10

The New Therapy to Antibiotic Resistant Bacteria——bacteriophage Preparations
下载PDF
导出
摘要 噬菌体发现之初,便被前苏联和东欧医学界用来治疗细菌感染。但是,随着抗生素时代的到来,人们慢慢忽略了对噬菌体在抗感染领域的深入研究。近年来由于耐药菌的频频出现,抗生素在抗感染领域面临前所未有的挑战,许多实验室开始把目光投向噬菌体制剂。本文回顾了噬菌体机制用于抗感染治疗的历史,介绍了目前噬菌体制剂的主要种类——活体噬菌体制剂和噬菌体裂解酶制剂的生物学特性、在抗感染领域的优劣势、应用情况和研究进展。 When phages were originally identified, the possibility of using them as antibacterial agents against pathogens was immediately recognized and put into practise based on the knowledge available at the time. However, with the advent of antibiotics a decline in the use of phage as therapeutics followed. Phages did, however, become more useful in the study of fundamental aspects of molecular biology and in the diagnostic laboratory for the identification of pathogenic bacteria. More recently, the original application of phage as therapeutics to treat human and animal infections has been rekindled, particularly in an era where antibiotic resistance has become so problematic. This paper reviews the history of phages as bactericidal agents and describes the main types of preparations of bacteriophage,including the biological characteristics, therapeutic application and and research progress.
作者 武英
出处 《国外医药(抗生素分册)》 CAS 2011年第5期223-228,共6页 World Notes on Antibiotics
关键词 噬菌体 噬菌体裂解酶 耐药菌 bacteriophage lysin antibiotic resistant bacteria
  • 相关文献

参考文献24

  • 1司樨东.噬菌体学[M].北京:科学出版社,1996.
  • 2Antje L.Bacteriophages:all alternative to antibiotics?[J].Biotech Devel Monit,1999,39(1):14.
  • 3姜焕焕,安小平,米志强,童贻刚.噬菌体治疗细菌性感染的进展[J].中国生物工程杂志,2010,30(12):116-122. 被引量:10
  • 4Kumari S,Harjai K,Chhibber S.Evidence to support the therapeutic potential of bacteriophage Kpn5 in bum wound infection caused by Klebsiella pneumoniae in BALB/c mice[J].J Microbiol Biotechnol,2010,20(5):935.
  • 5Brussow H,Kutter E.Phage ecology.In:Kutter E,sulakvelidze A,editors.bacteriophages:biology and application[M].Boca Raton,Fla,USA:CRC Press,2005:129.
  • 6Ackermann HW.acteriophage classification.In:Kutter E,SulakvelidzeA,editors.B acterioph ages:biology and applications[M].Boca Raton,FL:CRC Press,2005:67.
  • 7Carlton RM.Phage therapy:past history and future prospects[J].Arch Irmnunol Ther EW,1999,47(5):267.
  • 8钱震雯,岳启安,田凤丽.噬菌体治疗的研究概况[J].医学综述,2007,13(16):1256-1258. 被引量:14
  • 9王盛,童贻刚.噬菌体治疗研究进展[J].微生物学通报,2009,36(7):1019-1024. 被引量:34
  • 10Bruttin A,Brussow H.Human volunteers receiving Escherichia coli phage T4 orally:A safety test of phage therapy[J].Antimicrob Agents Chem other,2005,49(7):2874.

二级参考文献146

  • 1刘明河.细菌病毒——噬菌体的应用概况[J].微生物学杂志,2002,22(4):56-57. 被引量:10
  • 2陈晓春,王继文,曹永长,毕英佐,马静云.噬菌体在疾病治疗方面的应用及研究[J].动物医学进展,2005,26(1):32-35. 被引量:27
  • 3李艺,杨信怡,游雪甫.耐甲氧西林金葡菌的耐药分子机制研究[J].国外医药(抗生素分册),2005,26(4):173-177. 被引量:7
  • 4叶道成,朱成钢,史锋.噬菌体溶壁酶研究进展[J].中国生物工程杂志,2005,25(10):78-82. 被引量:5
  • 5Young R. Bacteriophage lysis: mechanism and regulation. Microbiology Review, 1992, 56(3) : 430 - 481 .
  • 6Loessner MJ. Bacteriophage endolysins-current state of research and applications. Current Opinion in Microbiology, 2005, 8(4) : 480 - 487.
  • 7Vollmer W, Blanot D, de Pedro MA. Peptidoglycan structure and architecture. FEMS microbiology reviews, 2008, 32(2) : 149 - 467.
  • 8Wang Y, Sun JH, Lu CP. Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine Streptococci. Current Microbiology, 2009. Published on line.
  • 9Loessner MJ, Maier SK, Daubek-Puza H, et al. Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. Journal of Bacteriology, 1997, 179 ( 9 ) : 2845 - 2851.
  • 10Loessner M J, Wendlinger G, Scherer S. Heterogeneous endolysin Listeria monocytogenes bacteriophages: class of enzyme and evidence for conserved holin genes within the siphoviral lysis cassettes. Molecular Microbiology, 1995, 16(6) : 1231 - 1241.

共引文献98

同被引文献103

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部